United States Anti Obesity Drugs Market Report 2016

November 2016 | 107 pages | ID: U9BB8CAB64EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti Obesity Drugs

Revenue, means the sales value of Anti Obesity Drugs

This report studies sales (consumption) of Anti Obesity Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Merck
• Roche
• GlaxoSmithKline
• AstraZeneca
• Boehringer Ingelheim
• Novo Nordisk
• Eisai
• Norgine
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Vivus
• Alizyme
• Rhythm Pharmaceuticals
• Shionogi
• Zafgan

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Anti Obesity Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Anti Obesity Drugs Market Report 2016

1 ANTI OBESITY DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti Obesity Drugs
1.2 Classification of Anti Obesity Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Anti Obesity Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Anti Obesity Drugs (2011-2021)
  1.4.1 United States Anti Obesity Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Anti Obesity Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTI OBESITY DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Anti Obesity Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anti Obesity Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anti Obesity Drugs Average Price by Manufactures (2015 and 2016)
2.4 Anti Obesity Drugs Market Competitive Situation and Trends
  2.4.1 Anti Obesity Drugs Market Concentration Rate
  2.4.2 Anti Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTI OBESITY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Anti Obesity Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Anti Obesity Drugs Price by Type (2011-2016)
3.4 United States Anti Obesity Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ANTI OBESITY DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Anti Obesity Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Anti Obesity Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ANTI OBESITY DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Anti Obesity Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck
  5.2.2 Anti Obesity Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Roche
  5.3.2 Anti Obesity Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline
  5.4.2 Anti Obesity Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 AstraZeneca
  5.5.2 Anti Obesity Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Boehringer Ingelheim
  5.6.2 Anti Obesity Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novo Nordisk
  5.7.2 Anti Obesity Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Eisai
  5.8.2 Anti Obesity Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Norgine
  5.9.2 Anti Obesity Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Arena Pharmaceuticals
  5.10.2 Anti Obesity Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Orexigen Therapeutics
5.12 Vivus
5.13 Alizyme
5.14 Rhythm Pharmaceuticals
5.15 Shionogi
5.16 Zafgan

6 ANTI OBESITY DRUGS MANUFACTURING COST ANALYSIS

6.1 Anti Obesity Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Anti Obesity Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Anti Obesity Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ANTI OBESITY DRUGS MARKET FORECAST (2016-2021)

10.1 United States Anti Obesity Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Anti Obesity Drugs Sales Forecast by Type (2016-2021)
10.3 United States Anti Obesity Drugs Sales Forecast by Application (2016-2021)
10.4 Anti Obesity Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti Obesity Drugs
Table Classification of Anti Obesity Drugs
Figure United States Sales Market Share of Anti Obesity Drugs by Type in 2015
Table Application of Anti Obesity Drugs
Figure United States Sales Market Share of Anti Obesity Drugs by Application in 2015
Figure United States Anti Obesity Drugs Sales and Growth Rate (2011-2021)
Figure United States Anti Obesity Drugs Revenue and Growth Rate (2011-2021)
Table United States Anti Obesity Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Anti Obesity Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti Obesity Drugs Sales Share by Manufacturers
Figure 2016 Anti Obesity Drugs Sales Share by Manufacturers
Table United States Anti Obesity Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Anti Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Anti Obesity Drugs Revenue Share by Manufacturers
Table 2016 United States Anti Obesity Drugs Revenue Share by Manufacturers
Table United States Market Anti Obesity Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Anti Obesity Drugs Average Price of Key Manufacturers in 2015
Figure Anti Obesity Drugs Market Share of Top 3 Manufacturers
Figure Anti Obesity Drugs Market Share of Top 5 Manufacturers
Table United States Anti Obesity Drugs Sales by Type (2011-2016)
Table United States Anti Obesity Drugs Sales Share by Type (2011-2016)
Figure United States Anti Obesity Drugs Sales Market Share by Type in 2015
Table United States Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
Table United States Anti Obesity Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti Obesity Drugs by Type (2011-2016)
Table United States Anti Obesity Drugs Price by Type (2011-2016)
Figure United States Anti Obesity Drugs Sales Growth Rate by Type (2011-2016)
Table United States Anti Obesity Drugs Sales by Application (2011-2016)
Table United States Anti Obesity Drugs Sales Market Share by Application (2011-2016)
Figure United States Anti Obesity Drugs Sales Market Share by Application in 2015
Table United States Anti Obesity Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Anti Obesity Drugs Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Anti Obesity Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Anti Obesity Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Anti Obesity Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Anti Obesity Drugs Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Anti Obesity Drugs Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Anti Obesity Drugs Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Anti Obesity Drugs Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Anti Obesity Drugs Sales Market Share (2011-2016)
Table Norgine Basic Information List
Table Norgine Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Norgine Anti Obesity Drugs Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Anti Obesity Drugs Sales Market Share (2011-2016)
Table Orexigen Therapeutics Basic Information List
Table Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orexigen Therapeutics Anti Obesity Drugs Sales Market Share (2011-2016)
Table Vivus Basic Information List
Table Vivus Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vivus Anti Obesity Drugs Sales Market Share (2011-2016)
Table Alizyme Basic Information List
Table Alizyme Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alizyme Anti Obesity Drugs Sales Market Share (2011-2016)
Table Rhythm Pharmaceuticals Basic Information List
Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rhythm Pharmaceuticals Anti Obesity Drugs Sales Market Share (2011-2016)
Table Shionogi Basic Information List
Table Shionogi Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shionogi Anti Obesity Drugs Sales Market Share (2011-2016)
Table Zafgan Basic Information List
Table Zafgan Anti Obesity Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zafgan Anti Obesity Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti Obesity Drugs
Figure Manufacturing Process Analysis of Anti Obesity Drugs
Figure Anti Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti Obesity Drugs
Table Distributors/Traders List
Figure United States Anti Obesity Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Anti Obesity Drugs Production Forecast by Type (2016-2021)
Table United States Anti Obesity Drugs Consumption Forecast by Application (2016-2021)